These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2492895)

  • 1. Familial hypophosphatemic rickets: bone mass measurements in children following therapy with calcitriol and supplemental phosphate.
    Block JE; Piel CF; Selvidge R; Genant HK
    Calcif Tissue Int; 1989 Feb; 44(2):86-92. PubMed ID: 2492895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical and trabecular bone density in X-linked hypophosphatemic rickets.
    Cheung M; Roschger P; Klaushofer K; Veilleux LN; Roughley P; Glorieux FH; Rauch F
    J Clin Endocrinol Metab; 2013 May; 98(5):E954-61. PubMed ID: 23533226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.
    Sullivan W; Carpenter T; Glorieux F; Travers R; Insogna K
    J Clin Endocrinol Metab; 1992 Sep; 75(3):879-85. PubMed ID: 1517380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density.
    Saggese G; Baroncelli GI; Bertelloni S; Perri G
    J Pediatr; 1995 Sep; 127(3):395-402. PubMed ID: 7658269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
    Glorieux FH; Marie PJ; Pettifor JM; Delvin EE
    N Engl J Med; 1980 Oct; 303(18):1023-31. PubMed ID: 6252463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone therapy in hypophosphatemic rickets.
    Wilson DM; Lee PD; Morris AH; Reiter EO; Gertner JM; Marcus R; Quarmby VE; Rosenfeld RG
    Am J Dis Child; 1991 Oct; 145(10):1165-70. PubMed ID: 1928011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypophosphatemic vitamin D resistant rickets (phosphate diabetes): bone mineral problems studied by 125I-computed tomography and microradiography.
    Exner GU; Prader A; Elsasser U; Rüegsegger P; Anliker M; Steendijk R
    Helv Paediatr Acta; 1980 Mar; 35(1):39-49. PubMed ID: 6250997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density of the spine and radius shaft in children with X-linked hypophosphatemic rickets (XLH).
    Oliveri MB; Cassinelli H; Bergadá C; Mautalen CA
    Bone Miner; 1991 Feb; 12(2):91-100. PubMed ID: 2015415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy.
    Petersen DJ; Boniface AM; Schranck FW; Rupich RC; Whyte MP
    J Bone Miner Res; 1992 Jun; 7(6):583-97. PubMed ID: 1414477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia.
    Lyles KW; Harrelson JM; Drezner MK
    J Clin Endocrinol Metab; 1982 Feb; 54(2):307-15. PubMed ID: 6976353
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
    N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypophosphatemic rickets: still misdiagnosed and inadequately treated.
    Greene WB; Kahler SG
    South Med J; 1985 Oct; 78(10):1179-84. PubMed ID: 2996152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral content in early-postmenopausal and postmenopausal osteoporotic women: comparison of measurement methods.
    Reinbold WD; Genant HK; Reiser UJ; Harris ST; Ettinger B
    Radiology; 1986 Aug; 160(2):469-78. PubMed ID: 3726129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutics of X-linked hypophosphatemic rickets.
    Latta K; Hisano S; Chan JC
    Pediatr Nephrol; 1993 Dec; 7(6):744-8. PubMed ID: 8130097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercalciuric hypophosphatemic rickets, mineral balance, bone histomorphometry, and therapeutic implications of hypercalciuria.
    Chen C; Carpenter T; Steg N; Baron R; Anast C
    Pediatrics; 1989 Aug; 84(2):276-80. PubMed ID: 2787497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets.
    Rivkees SA; el-Hajj-Fuleihan G; Brown EM; Crawford JD
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1514-8. PubMed ID: 1464657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good metabolic control prevents post-surgical imbalance of mineral metabolism in patients with X-linked hypophosphatemic rickets.
    Baroncelli GI; Bertelloni S; Saggese G
    J Pediatr Endocrinol Metab; 2001 Feb; 14(2):223-4. PubMed ID: 11305803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.